These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 29884487

  • 1. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study.
    Hoffmann T, Assmann A, Dierksen A, Roussel E, Ullrich S, Lichtenberg A, Albert A, Sixt S.
    J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1564-1573.e8. PubMed ID: 29884487
    [Abstract] [Full Text] [Related]

  • 2. Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes.
    Uber WE, Toole JM, Stroud MR, Haney JS, Lazarchick J, Crawford FA, Ikonomidis JS.
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1469-77.e2. PubMed ID: 21457998
    [Abstract] [Full Text] [Related]

  • 3. Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).
    Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1320-7. PubMed ID: 21550261
    [Abstract] [Full Text] [Related]

  • 4. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
    Feih JT, Juul JJ, G Rinka JR, Baumann Kreuziger LM, Pagel PS, Tawil JN.
    Ann Card Anaesth; 2019 Dec; 22(4):388-393. PubMed ID: 31621674
    [Abstract] [Full Text] [Related]

  • 5. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
    Tomita E, Takase H, Tajima K, Suematsu Y.
    Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
    [Abstract] [Full Text] [Related]

  • 6. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
    Gelsomino S, Lorusso R, Romagnoli S, Bevilacqua S, De Cicco G, Billè G, Stefàno P, Gensini GF.
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
    [Abstract] [Full Text] [Related]

  • 7. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [Abstract] [Full Text] [Related]

  • 8. Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery.
    Brase J, Finger B, He J, Wirtz K, Stun L, McMillen R, Flynn B.
    Ann Thorac Surg; 2016 Jul; 102(1):35-40. PubMed ID: 26874365
    [Abstract] [Full Text] [Related]

  • 9. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
    Chapman AJ, Blount AL, Davis AT, Hooker RL.
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1314-8; discussion 1318-9. PubMed ID: 21601468
    [Abstract] [Full Text] [Related]

  • 10. Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?
    Okonta KE, Edwin F, Falase B.
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):690-4. PubMed ID: 22811512
    [Abstract] [Full Text] [Related]

  • 11. Recombinant activated factor VII in cardiac surgery: single-center experience.
    Singh SP, Chauhan S, Choudhury M, Malik V, Choudhary SK.
    Asian Cardiovasc Thorac Ann; 2014 Feb; 22(2):148-54. PubMed ID: 24585784
    [Abstract] [Full Text] [Related]

  • 12. Intraoperative use of recombinant activated factor VII during complex aortic surgery.
    Goksedef D, Panagopoulos G, Nassiri N, Levine RL, Hountis PG, Plestis KA.
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1198-204. PubMed ID: 22285329
    [Abstract] [Full Text] [Related]

  • 13. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK, Lobato RL, Bartlett B, Klanjac M, Mora-Mangano CT, Soran PD, Oakes DA, Hill CC, van der Starre PJ.
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [Abstract] [Full Text] [Related]

  • 14. Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa.
    Mazer CD, Leong-Poi H, Mahoney J, Latter D, Strauss BH, Teitel JM.
    Semin Cardiothorac Vasc Anesth; 2007 Dec; 11(4):261-4. PubMed ID: 18270189
    [Abstract] [Full Text] [Related]

  • 15. Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations.
    Andersen ND, Bhattacharya SD, Williams JB, Fosbol EL, Lockhart EL, Patel MB, Gaca JG, Welsby IJ, Hughes GC.
    Ann Thorac Surg; 2012 Jun; 93(6):1921-8; discussion 1928-9. PubMed ID: 22551846
    [Abstract] [Full Text] [Related]

  • 16. Recombinant activated factor VII: a solution to refractory haemorrhage in vascular surgery?
    Warren OJ, Alcock EM, Choong AM, Leff DR, Van Herzeele I, Darzi AW, Athanasiou T, Cheshire NJ.
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):145-52. PubMed ID: 17964194
    [Abstract] [Full Text] [Related]

  • 17. Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation.
    Anselmi A, Guinet P, Ruggieri VG, Aymami M, Lelong B, Granry S, Malledant Y, Le Tulzo Y, Gueret P, Verhoye JP, Flecher E.
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):78-84. PubMed ID: 25908783
    [Abstract] [Full Text] [Related]

  • 18. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
    Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA, Australian and New Zealand Haemostasis Registry.
    Anesth Analg; 2009 Dec; 109(6):1908-15. PubMed ID: 19923520
    [Abstract] [Full Text] [Related]

  • 19. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F, Castillo JG, Rahmanian PB, Scurlock C, Fischer G, Adams DH.
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [Abstract] [Full Text] [Related]

  • 20. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
    Li Y, Zhao W, Luo Q, Wu X, Ding J, Yan F.
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.